Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Ophthalmology

 

COVID vaccine: Shot in the arm the markets needed?

Pfizer shares rocketed 15% on Monday with news of a vaccine that's more than 90% effective. But lab and telehealth shares plummeted upon the announcement while hospitals, care homes and outpatient groups recouped some of their YTD losses. HBI explores what a vaccine might mean across the five sub-sectors.
November 12, 2020

Artemis “enters sales process”

Artemis, Germany's second largest ophthalmology chain by revenue, has entered a sales process, HBI hears from multiple sources.
November 5, 2020

Medica buys Irish diagnostics/teleradiology group for 8-10x EBITDA

The UK's largest teleradiology provider Medica has acquired Global Diagnostics Ireland (GDI), which does eye screening, diagnostic managed services and teleradiology. With only a minority of revenue from the latter, we ask CEO Stuart Quin what this expansion outside of Medica's core business means for its strategy.
November 5, 2020

European operators brace for second wave

COVID's second wave looks either imminent, or is already starting to hit in many jurisdictions. Wave one saw lockdowns and closures - and not all closures were temporary. Will wave two be any different? HBI has been talking to operators across EMEA to see if forewarned is forearmed, how they predict the next few months will go, and what lessons have been learned.
October 1, 2020

Multiples drop 10-15% in German outpatient sector

EBITDA multiples paid in the German outpatient sector have fallen 10-15% from pre-COVID levels because of market uncertainty due to the pandemic, an advisor tracking the space tells HBI.
September 17, 2020

Optegra sales process begins

Multiple sources tell HBI that UK, Czechia and Poland-based ophthalmology platform Optegra is for sale. We take a look at the detailed figures behind the prospective sale, speculate as to price and buyers, and speak to an operator source about his view of the business.
September 10, 2020

Coronaria CEO: no plan to sell optical retail unit after ophtha merger

Finland’s fourth-largest healthcare operator, Coronaria, has built the biggest ophthalmology business in Finland and is also the largest player in rehabilitation. We talk to CEO Teppo Lindén about his plans, why he is keeping the optician arm and the impact of Covid.
August 27, 2020

What does a good post-COVID outpatient clinic look like?

Outpatient activity all but came to a standstill as the COVID crisis tightened its grip. A panel of experts comprising Richard Banks, Chief Strategy Officer at international fertility player Virtus Health, Martin Bundschu, Director at Germany-based optical specialist Smile Eyes, former Colosseum Dental CEO Tomas Aubell, and L.E.K. Consulting's global co-head of healthcare Ben Faircloth joined an HBI-365 audience last week to discuss what a good outpatient clinic post-COVID might look like, and how markets have been affected.
July 30, 2020

Adding value post-COVID – where are the easy wins?

How do you add value to a business in a post COVID world - and are there any easy wins for new acquisitions? On Wednesday last week, an online audience heard HBI365's lively Q&A panel with with Ameos CEO Dr Axel Paeger, McKinsey partner Sebastian Sieler, and L Catterton managing partner Chinta Bhagat.
July 23, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us